Causes of Death in Patients With Celiac Disease in a Population-Based Swedish Cohort | Allergy and Clinical Immunology | JAMA Internal Medicine | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
Farrell  RJKelly  CP Celiac sprue.  N Engl J Med. 2002;346180- 188PubMedGoogle ScholarCrossref
2.
Cooke  WTHolmes  GKT Coeliac Disease.  London, England Churchill Livingstone1984;
3.
Greco  LMaki  MDonator  FVisakorpi  JK Epidemiology of coeliac disease in Europe and Mediterranean area. Auricchio  SVisakorpi  JKeds. Common Food Intolerances 1 Epidemiology of Coeliac Disease Basel, Switzerland: Karger1992;25- 44Google Scholar
4.
Rossi  TMAlbini  CHKumar  V Incidence of celiac disease identified by the presence of serum endomysial antibodies in children with chronic diarrhea, short stature, or insulin-dependent diabetes mellitus.  J Pediatr. 1993;123262- 264PubMedGoogle ScholarCrossref
5.
Ussher  RYeong  MLStace  N Coeliac disease: incidence and prevalence in Wellington 1985-92.  N Z Med J. 1994;107195- 197PubMedGoogle Scholar
6.
Cavell  BStenhammar  LAscher  H  et al.  Increasing incidence of childhood coeliac disease in Sweden: results of a national study.  Acta Paediatr. 1992;81589- 592PubMedGoogle ScholarCrossref
7.
Chorzelski  TPSulej  JTchorzewska  HJablonska  SBeutner  EHKumar  V IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease.  Ann N Y Acad Sci. 1983;420325- 334PubMedGoogle ScholarCrossref
8.
Burgin-Wolff  AHadziselimovic  F Screening test for coeliac disease.  Lancet. 1997;3491843- 1844PubMedGoogle ScholarCrossref
9.
Feighery  C Fortnightly review: coeliac disease.  BMJ. 1999;319236- 239PubMedGoogle ScholarCrossref
10.
Fasano  ACatassi  C Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum.  Gastroenterology. 2001;120636- 651PubMedGoogle ScholarCrossref
11.
Talal  AHMurray  JAGoeken  JASivitz  WI Celiac disease in an adult population with insulin-dependent diabetes mellitus: use of endomysial antibody testing.  Am J Gastroenterol. 1997;921280- 1284PubMedGoogle Scholar
12.
Pueschel  SMRomano  CFailla  P  et al.  A prevalence study of celiac disease in persons with Down syndrome residing in the United States of America.  Acta Paediatr. 1999;88953- 956PubMedGoogle ScholarCrossref
13.
Hill  IDHorvath  KFasano  A Epidemiology of celiac disease.  Am J Gastroenterol. 1995;90163- 164PubMedGoogle Scholar
14.
Hill  IFasano  ASchwartz  RCounts  DGlock  MHorvath  K The prevalence of celiac disease in at-risk groups of children in the United States.  J Pediatr. 2000;13686- 90PubMedGoogle ScholarCrossref
15.
Not  THorvath  KHill  ID  et al.  Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors.  Scand J Gastroenterol. 1998;33494- 498PubMedGoogle ScholarCrossref
16.
Fasano  A Where have all the American celiacs gone?  Acta Paediatr Suppl. 1996;41220- 24PubMedGoogle ScholarCrossref
17.
Catassi  CFabiani  ERatsch  IM  et al.  The coeliac iceberg in Italy: a multicentre antigliadin antibodies screening for coeliac disease in school-age subjects.  Acta Paediatr Suppl. 1996;41229- 35PubMedGoogle ScholarCrossref
18.
Ivarsson  APersson  LAJuto  PPeltonen  MSuhr  OHernell  O High prevalence of undiagnosed coeliac disease in adults: a Swedish population-based study.  J Intern Med. 1999;24563- 68PubMedGoogle ScholarCrossref
19.
Johnston  SDWatson  RGMcMillan  SASloan  JLove  AH Coeliac disease detected by screening is not silent—simply unrecognized.  QJM. 1998;91853- 860PubMedGoogle ScholarCrossref
20.
Volta  UBellentani  SBianchi  FB  et al.  High prevalence of celiac disease in Italian general population.  Dig Dis Sci. 2001;461500- 1505PubMedGoogle ScholarCrossref
21.
Catassi  CRatsch  IMFabiani  E  et al.  Coeliac disease in the year 2000: exploring the iceberg.  Lancet. 1994;343200- 203PubMedGoogle ScholarCrossref
22.
Maki  MKallonen  KLahdeaho  MLVisakorpi  JK Changing pattern of childhood coeliac disease in Finland.  Acta Paediatr Scand. 1988;77408- 412PubMedGoogle ScholarCrossref
23.
Holmes  GKPrior  PLane  MRPope  DAllan  RN Malignancy in coeliac disease: effect of a gluten free diet.  Gut. 1989;30333- 338PubMedGoogle ScholarCrossref
24.
Catassi  CFabiani  ECorrao  G  et al.  Risk of non-Hodgkin lymphoma in celiac disease.  JAMA. 2002;2871413- 1419PubMedGoogle ScholarCrossref
25.
Collin  PReunala  TPukkala  ELaippala  PKeyrilainen  OPasternack  A Coeliac disease: associated disorders and survival.  Gut. 1994;351215- 1218PubMedGoogle ScholarCrossref
26.
Swinson  CMSlavin  GColes  ECBooth  CC Coeliac disease and malignancy.  Lancet. 1983;1111- 115PubMedGoogle ScholarCrossref
27.
Cooper  BTHolmes  GKFerguson  RCooke  WT Celiac disease and malignancy.  Medicine (Baltimore). 1980;59249- 261PubMedGoogle ScholarCrossref
28.
Marsch  SHeer  MSulser  HHany  A Risk of malignancies in celiac disease: a retrospective study [in German].  Schweiz Rundsch Med Prax. 1990;79533- 536PubMedGoogle Scholar
29.
Nielsen  OHJacobsen  OPedersen  ER  et al.  Non-tropical sprue: malignant diseases and mortality rate.  Scand J Gastroenterol. 1985;2013- 18PubMedGoogle ScholarCrossref
30.
Pricolo  VEMangi  AAAswad  BBland  KI Gastrointestinal malignancies in patients with celiac sprue.  Am J Surg. 1998;176344- 347PubMedGoogle ScholarCrossref
31.
Askling  JLinet  MGridley  GHalstensen  TSEkbom  A Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis in Sweden.  Gastroenterology. 2002;1231428- 1435Google ScholarCrossref
32.
Valdimarsson  TToss  GRoss  ILofman  OStrom  M Bone mineral density in coeliac disease.  Scand J Gastroenterol. 1994;29457- 461PubMedGoogle ScholarCrossref
33.
Ventura  AMagazzu  GGreco  LSIGEP Study Group for Autoimmune Disorders in Celiac Disease, Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease.  Gastroenterology. 1999;117297- 303PubMedGoogle ScholarCrossref
34.
Page  SRLloyd  CAHill  PGPeacock  IHolmes  GK The prevalence of coeliac disease in adult diabetes mellitus.  QJM. 1994;87631- 637PubMedGoogle Scholar
35.
Cronin  CCShanahan  F Insulin-dependent diabetes mellitus and coeliac disease.  Lancet. 1997;3491096- 1097PubMedGoogle ScholarCrossref
36.
Counsell  CETaha  ARuddell  WS Coeliac disease and autoimmune thyroid disease.  Gut. 1994;35844- 846PubMedGoogle ScholarCrossref
37.
Wright  DH The major complications of coeliac disease.  Baillieres Clin Gastroenterol. 1995;9351- 369PubMedGoogle ScholarCrossref
38.
Mora  SWeber  GBarera  G  et al.  Effect of gluten-free diet on bone mineral content in growing patients with celiac disease.  Am J Clin Nutr. 1993;57224- 228PubMedGoogle Scholar
39.
Vasquez  HMazure  RGonzalez  D  et al.  Risk of fractures in celiac disease patients: a cross-sectional, case-control study.  Am J Gastroenterol. 2000;95183- 189PubMedGoogle ScholarCrossref
40.
Corrao  GCorazza  GRBagnardi  V  et al.  Mortality in patients with coeliac disease and their relatives: a cohort study.  Lancet. 2001;358356- 361PubMedGoogle ScholarCrossref
41.
Logan  RFRifkind  EATurner  IDFerguson  A Mortality in celiac disease.  Gastroenterology. 1989;97265- 271PubMedGoogle Scholar
42.
Cottone  MTermini  AOliva  L  et al.  Mortality and causes of death in celiac disease in a Mediterranean area.  Dig Dis Sci. 1999;442538- 2541PubMedGoogle ScholarCrossref
43.
Naessen  TParker  RPersson  IZack  MAdami  HO Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983.  Am J Epidemiol. 1989;130289- 299PubMedGoogle Scholar
44.
Breslow  NEDay  NE Statistical methods in cancer research, volume II: the design and analysis of cohort studies.  IARC Sci Publ. 1987;821- 406PubMedGoogle Scholar
45.
Anderson  LMDiwan  BAFear  NTRoman  E Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models.  Environ Health Perspect. 2000;108 ((suppl 3)) 573- 594PubMedGoogle ScholarCrossref
46.
Alpan  ORudomen  GMatzinger  P The role of dendritic cells, B cells, and M cells in gut-oriented immune responses.  J Immunol. 2001;1664843- 4852PubMedGoogle ScholarCrossref
47.
Fujihashi  KDohi  TKweon  MN  et al.  Gammadelta T cells regulate mucosally induced tolerance in a dose-dependent fashion.  Int Immunol. 1999;111907- 1916PubMedGoogle ScholarCrossref
48.
Anderson  CCMatzinger  P Immunity or tolerance: opposite outcomes of microchimerism from skin grafts.  Nat Med. 2001;780- 87PubMedGoogle ScholarCrossref
49.
Whorwell  PJAlderson  MRFoster  KJWright  R Death from ischaemic heart-disease and malignancy in adult patients with coeliac disease.  Lancet. 1976;2113- 114PubMedGoogle ScholarCrossref
50.
Cunningham-Rundles  CCooper  DLDuffy  TPStrauchen  J Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency.  Am J Hematol. 2002;69171- 178PubMedGoogle ScholarCrossref
51.
Tossing  G Immunodeficiency and its relation to lymphoid and other malignancies.  Ann Hematol. 1996;73163- 167PubMedGoogle ScholarCrossref
52.
Zeier  MHartschuh  WWiesel  MLehnert  TRitz  E Malignancy after renal transplantation.  Am J Kidney Dis. 2002;39E5PubMedGoogle ScholarCrossref
53.
Pocecco  MVentura  A Coeliac disease and insulin-dependent diabetes mellitus: a causal association?  Acta Paediatr. 1995;841432- 1433PubMedGoogle ScholarCrossref
54.
Maki  MHallstrom  OVerronen  P  et al.  Reticulin antibody, arthritis, and coeliac disease in children [letter].  Lancet. 1988;1479- 480PubMedGoogle ScholarCrossref
55.
Lepore  LMartelossi  SPennesi  M  et al.  Prevalence of celiac disease in patients with juvenile chronic arthritis.  J Pediatr. 1996;129311- 313PubMedGoogle ScholarCrossref
56.
Auricchio  STroncone  RMaurano  F Coeliac disease in the year 2000.  Ital J Gastroenterol Hepatol. 1999;31773- 780PubMedGoogle Scholar
57.
Shanahan  FMcKenna  RMcCarthy  CFDrury  MI Coeliac disease and diabetes mellitus: a study of 24 patients with HLA typing.  QJM. 1982;51329- 335PubMedGoogle Scholar
58.
Maki  MCollin  P Coeliac disease.  Lancet. 1997;3491755- 1759PubMedGoogle ScholarCrossref
59.
Sollid  LMThorsby  E HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis.  Gastroenterology. 1993;105910- 922PubMedGoogle Scholar
60.
Maki  M Coeliac disease and autoimmunity due to unmasking of cryptic epitopes?  Lancet. 1996;3481046- 1047PubMedGoogle ScholarCrossref
61.
Dieterich  WEhnis  TBauer  M  et al.  Identification of tissue transglutaminase as the autoantigen of celiac disease.  Nat Med. 1997;3797- 801PubMedGoogle ScholarCrossref
62.
Reunala  T Dermatitis herpetiformis: coeliac disease of the skin.  Ann Med. 1998;30416- 418PubMedGoogle ScholarCrossref
63.
Bodvarsson  SJonsdottir  IFreysdottir  JLeonard  JNFry  LValdimarsson  H Dermatitis herpetiformis: an autoimmune disease due to cross-reaction between dietary glutenin and dermal elastin?  Scand J Immunol. 1993;38546- 550PubMedGoogle ScholarCrossref
64.
Sorensen  HTThulstrup  AMBlomqvist  PNorgaard  BFonager  KEkbom  A Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data.  Gut. 1999;44736- 738PubMedGoogle ScholarCrossref
65.
Kingham  JGParker  DR The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences.  Gut. 1998;42120- 122PubMedGoogle ScholarCrossref
66.
Lindberg  JAhren  CIwarson  S Intestinal villous atrophy in chronic active hepatitis.  Scand J Gastroenterol. 1979;141015- 1018PubMedGoogle Scholar
67.
Sjoberg  KLindgren  SEriksson  S Frequent occurrence of non-specific gliadin antibodies in chronic liver disease: endomysial but not gliadin antibodies predict coeliac disease in patients with chronic liver disease.  Scand J Gastroenterol. 1997;321162- 1167PubMedGoogle ScholarCrossref
68.
Lindgren  SSjoberg  KEriksson  S Unsuspected coeliac disease in chronic "cryptogenic" liver disease.  Scand J Gastroenterol. 1994;29661- 664PubMedGoogle ScholarCrossref
69.
Jacobsen  MBFausa  OElgjo  KSchrumpf  E Hepatic lesions in adult coeliac disease.  Scand J Gastroenterol. 1990;25656- 662PubMedGoogle ScholarCrossref
70.
O'Donoghue  DJ Fatal pneumococcal septicaemia in coeliac disease.  Postgrad Med J. 1986;62229- 230PubMedGoogle ScholarCrossref
71.
Williams  AJAsquith  PStableforth  DE Susceptibility to tuberculosis in patients with coeliac disease.  Tubercle. 1988;69267- 274PubMedGoogle ScholarCrossref
72.
Johnston  SDRobinson  J Fatal pneumococcal septicaemia in a coeliac patient.  Eur J Gastroenterol Hepatol. 1998;10353- 354PubMedGoogle ScholarCrossref
73.
O'Grady  JGStevens  FMMcCarthy  CF Celiac disease: does hyposplenism predispose to the development of malignant disease?  Am J Gastroenterol. 1985;8027- 29PubMedGoogle Scholar
74.
Corazza  GRBullen  AWHall  RRobinson  PJLosowsky  MS Simple method of assessing splenic function in coeliac disease.  Clin Sci. 1981;60109- 113PubMedGoogle Scholar
75.
Hermaszewski  RARigby  SDalgleish  AG Coeliac disease presenting with cerebellar degeneration.  Postgrad Med J. 1991;671023- 1024PubMedGoogle ScholarCrossref
76.
Thun  MJPeto  RLopez  AD  et al.  Alcohol consumption and mortality among middle-aged and elderly US adults.  N Engl J Med. 1997;3371705- 1714PubMedGoogle ScholarCrossref
77.
Jain  ABuddhiraja  SKhurana  B  et al.  Risk factors for duodenal ulcer in north India.  Trop Gastroenterol. 1999;2036- 39PubMedGoogle Scholar
78.
McNeish  ASAnderson  CM Coeliac disease: the disorder in childhood.  Clin Gastroenterol. 1974;3127- 144PubMedGoogle Scholar
79.
Berg  NOLindberg  T Incidence of coeliac disease and transient gluten intolerance in children in a Swedish urban community.  Acta Paediatr Scand. 1979;68397- 400PubMedGoogle ScholarCrossref
Original Investigation
July 14, 2003

Causes of Death in Patients With Celiac Disease in a Population-Based Swedish Cohort

Author Affiliations

From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Md (Drs Peters and Linet and Ms Gridley); and Department of Medical Epidemiology, Karolinska Institute, Stockholm, Sweden (Drs Askling and Ekbom). The authors have no relevant financial interest in this article.

Arch Intern Med. 2003;163(13):1566-1572. doi:10.1001/archinte.163.13.1566
Abstract

Background  Patients with celiac disease have an increased risk of death from gastrointestinal malignancies and lymphomas, but little is known about mortality from other causes and few studies have assessed long-term outcomes.

Methods  Nationwide data on 10 032 Swedish patients hospitalized from January 1, 1964, through December 31, 1993, with celiac disease and surviving at least 12 months were linked with the national mortality register. Mortality risks were computed as standardized mortality ratios (SMRs), comparing mortality rates of patients with celiac disease with rates in the general Swedish population.

Results  A total of 828 patients with celiac disease died during the follow-up period (1965-1994). For all causes of death combined, mortality risks were significantly elevated: 2.0-fold (95% confidence interval [CI], 1.8-2.1) among all patients with celiac disease and 1.4-fold (95% CI, 1.2-1.6) among patients with celiac disease with no other discharge diagnoses at initial hospitalization. The overall SMR did not differ by sex or calendar year of initial hospitalization, whereas mortality risk in patients hospitalized with celiac disease before the age of 2 years was significantly lower by 60% (95% CI, 0.2-0.8) compared with the same age group of the general population. Mortality risks were elevated for a wide array of diseases, including non-Hodgkin lymphoma (SMR, 11.4), cancer of the small intestine (SMR, 17.3), autoimmune diseases (including rheumatoid arthritis [SMR, 7.3] and diffuse diseases of connective tissue [SMR, 17.0]), allergic disorders (such as asthma [SMR, 2.8]), inflammatory bowel diseases (including ulcerative colitis and Crohn disease [SMR, 70.9]), diabetes mellitus (SMR, 3.0), disorders of immune deficiency (SMR, 20.9), tuberculosis (SMR, 5.9), pneumonia (SMR, 2.9), and nephritis (SMR, 5.4).

Conclusion  The elevated mortality risk for all causes of death combined reflected, for the most part, disorders characterized by immune dysfunction.

×